KLP Kapitalforvaltning AS Invests $157.54 Million in UnitedHealth Group Incorporated (NYSE:UNH)

KLP Kapitalforvaltning AS bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 311,435 shares of the healthcare conglomerate's stock, valued at approximately $157,543,000. UnitedHealth Group accounts for about 0.7% of KLP Kapitalforvaltning AS's portfolio, making the stock its 17th biggest holding.

A number of other hedge funds have also added to or reduced their stakes in UNH. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $25,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group in the 4th quarter worth approximately $30,000. Promus Capital LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $32,000. RPg Family Wealth Advisory LLC purchased a new position in UnitedHealth Group in the 3rd quarter worth $37,000. Finally, Pillar Financial Advisors LLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at about $40,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Up 0.9 %

UNH stock traded up $4.67 on Wednesday, hitting $518.10. 3,253,715 shares of the company's stock were exchanged, compared to its average volume of 4,086,604. The firm has a 50 day moving average price of $508.60 and a two-hundred day moving average price of $545.37. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The stock has a market cap of $473.92 billion, a P/E ratio of 33.43, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group's revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.83 EPS. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.62%. UnitedHealth Group's dividend payout ratio is currently 54.19%.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.33% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several research analysts have recently issued reports on UNH shares. Deutsche Bank Aktiengesellschaft raised their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a report on Tuesday, December 3rd. Piper Sandler decreased their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research note on Thursday, January 2nd. Barclays reduced their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research note on Friday, January 17th. Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. Finally, Stephens increased their target price on UnitedHealth Group from $605.00 to $675.00 and gave the company an "overweight" rating in a report on Thursday, December 5th. Twenty research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Buy" and an average price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.